news + headlines

Potential HIV prophylaxis enters Canadian pilot trialAn established treatment for HIV is being studied for real-world use as prophylaxis in two Canadian trials beginning in late March. Truvada (emtricitabine and tenofovir disoproxil fumarate) is already approved in the United States for the prevention of HIV.
Expanded HIV testing may find more acute infections as well as more late presentersExpanding HIV testing into local hospitals and primary care may not only find more people who have lived with HIV for a long time without knowing it, but may also find more people who have only recently become infected, a pilot study from Vancouver in Canada has found.
PEP Can Stop You From Getting HIV: A Conversation with ACT's Duncan Maclachlan.Week-long series on PEP. PositiveLite talks with Duncan MacLachlan, the Manager of Community Health Programs at the AIDS Committee of Toronto (ACT), to find out about PEP, its effectiveness and its availability.